Alexander J. Annala

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Pre-clinical studies indicate that neural stem cells (NSCs) can limit or reverse CNS damage through direct cell replacement, promotion of regeneration, or delivery of therapeutic agents. Immortalized NSC lines are in growing demand due to the inherent limitations of adult patient-derived NSCs, including availability, expandability, potential for genetic(More)
  • 1